Thursday, June 23, 2016 | 9:00 a.m. – 10:15 a.m.
Over 16,000 people have died from overdosing on prescription opioids in the United States in the past year. The prescription and misuse of these drugs—and the addiction to them—have surpassed marijuana and are decimating a generation of adolescents and young adults. Heroin use and overdose deaths are on the rise as well. This epidemic was born within another epidemic: chronic pain. This session will review how we got to this point, the nature of today’s epidemic, and possible solutions for changing course at this crucial time.
Upon completion of this session, attendees will be able to:
- Describe the cultural medical factors which have led to the epidemic of prescription drug use.
- Analyze the trends that are sustaining both the use and overuse of these medications.
- Discuss the transition from prescription drugs to heroin as a dangerous drug for our young people.
- Review non-opioid approaches to the treatment of chronic pain.
Thursday, June 23, 2016 | 10:45 a.m. – 11:45 a.m.
In this session, attendees will learn the realities of pain, addiction, and aging—along with the concurrent, multidisciplinary interventions that are most effective. It addresses the psychological and emotional components of chronic pain, and explores the skills patients need to cope with chronic pain that have primary biomedical origins. Attendees will learn about a treatment approach that combines pharmacological, adjunct wellness, and psychological therapeutic interventions in addressing an aging population that suffers from addiction. Attendees will learn the language of generational, age-specific treatment and the two primary functions of psychotherapy in treating chronic pain. You’ll also discover which non-opioid medications, alternatives, and wellness therapies are most effective, and how the risks of post-surgical relapse can be avoided.
Upon completion of this session, attendees will be able to:
- Integrate knowledge of generational differences and values, aging trends, and multi-symptomatic profiles into clinical practice.
- Apply psychotherapeutic counseling techniques that address two primary functions: amelioration of pain by addressing psychogenic properties; and guiding the development of skills for coping with bio-medically based pain.
- Develop strategies that support a collaborative, medical, psychological approach to addiction and chronic pain treatment and develop relapse prevention skills within an aging population.
Thursday, June 23, 2016 | 1:15 p.m. – 2:45 p.m.
Moderator:
Panelists:
Dean Drosnes, MD, Caron Treatment Centers
Few patients present a more difficult challenge for treatment professionals than the individual with co-occurring pain and substance dependence. In this session, a panel of treatment experts will discuss strategies for achieving a balanced treatment approach that allows patients to achieve recovery and deal better with the pain that emerges in their everyday lives. Panelists will discuss multidisciplinary strategies, as well as the appropriateness of medication- and non-medication based treatments for these patients. They also will explore how clinicians can assist patients in changing their perception of pain and how it affects their daily living.
Upon completion of this session, attendees will be able to:
- Identify and analyze the dynamics of co-occurring pain and substance dependence.
- Develop strategies that balance the pain management and substance use treatment needs of the patient.
- Apply communication techniques for having productive discussions with patients about the impact of pain in their lives, and how to cope with various levels of pain.
Sponsored by: Retreat Premier Addiction Treatment Centers
Thursday, June 23, 2016 | 3:15 p.m. – 4:45 p.m.
Moderator:
Panelists:
Thomas M. Baier, MHS, LPC, CADC, CCS, Senior Executive Director for Recovery Services, JEVS Human Services
Melissa A. Townes, CIP, CTR, Regional Service Coordinator, White Deer Run Treatment Network
Melissa A. Townes, CIP, CTR, Regional Service Coordinator, White Deer Run Treatment Network
With both prescription drug and heroin use soaring in many communities, the medical community and the specialty addiction treatment sector are exploring how to effectively manage this influx of patients. A panel of leaders representing the addiction treatment and pain management fields will discuss what the evidence is showing about what works best in treatment, including treatment for special populations such as young people. The impact of buprenorphine's significant growth will be assessed, as will the evolving role of methadone treatment. The panelists also will discuss the important components of supportive counseling and mind-body interventions, drawing a road map for comprehensive clinical care.
Upon completion of this session, attendees will be able to:
- Assess the latest evidence on the effectiveness of medication, counseling and other approaches to treatment for opioid dependence.
- Evaluate strategies for matching treatment to specific individuals' and subpopulations' needs.
- Outline the key components of a comprehensive treatment strategy for opioid dependence.
Sponsored by: White Deer Run Treatment Network
Friday, June 24, 2016 | 8:30 a.m. – 9:30 a.m.
The emergence of buprenorphine as an attractive alternative option in medication-assisted treatment for opioid addiction has improved access to care and engagement in treatment for some, and this has a number of leaders calling for fewer federal restrictions on prescribing the drug. However, the use of buprenorphine has also encountered some unexpected challenges. This presentation will outline the early history of buprenorphine treatment and will cite key research findings in an attempt to separate fact from fiction on this much-discussed medication. Dr. Stein will address how buprenorphine has changed the treatment landscape thus far, where and for whom it has been most successful, and where it has fallen short. This plenary will address the most likely trajectory for this treatment option going forward.
Upon completion of this presentation, attendees will be able to:
- Outline key policy initiatives and positions affecting the delivery of buprenorphine treatment.
- Cite the greatest benefits and drawbacks that the emergence of buprenorphine has brought to the treatment field and its patients.
- Cite the ways in which buprenorphine treatment has altered the delivery of addiction treatment services
Friday, June 24, 2016 | 10:00 a.m. – 11:00 a.m.
Changing federal regulations, new medical treatments, and disease integration have moved where and how we treat patients with opioid dependence. This session will address the changes in treatment settings, along with the requirements and who is and isn’t allowed to prescribe. We will review the changes into global payment systems and how these outcomes will affect patients with opioid dependence. It will address the public health crisis that is killing more people than motor vehicle accidents nationally, yet treatment is inaccessible. Treatment accessibility issues including shortage of providers, best practice models of care, and the utilization of multidisciplinary approaches. This session will focus on ways to support widespread dissemination of treatment for opioid dependence using a team approach.
Upon completion of this session, attendees will be able to:
- Understand the barriers to treatment expansion for opioid dependence in the office setting
- Identify the changes in regulations that allow treatment for opioid dependence
- List the successes of team-based approaches to treatment expansion
P03 -The Vital Link: Engaging Families and Communities in Combating Prescription Drug Abuse Panel Discussion
Friday, June 24, 2016 | 11:00 a.m. – 12:30 p.m.
Moderator:
Panelists:
Karen A. Plavan, PhD, CIP, Executive Director, The Oasis Recovery Center & Chair, (CLEAR)
Liz Sump, MA, LMHC, Behavioral Health Therapist, Questa Health Center
Liz Sump, MA, LMHC, Behavioral Health Therapist, Questa Health Center
Any successful response to a public health crisis involves engaging all key sectors of the community in a unifying fashion. In this session, a panel of treatment and policy leaders will assess the progress of key public policy and community engagement initiatives designed to combat the opioid crisis. Widespread policy initiatives such as overdose prevention and other harm reduction approaches, as well as state prescription drug monitoring programs (PDMPs) targeting the physician community, will be assessed. Panelists will also discuss the critical importance of engaging families in prevention, treatment and recovery efforts.
Upon completion of this session, attendees will be able to:
- Identify the key components of the most prominent policy strategies to combat the public health crisis around opioid addiction.
- Evaluate the potential effectiveness of harm reduction strategies to combat opioid misuse.
- Implement specific strategies for engaging families in the prevention and treatment of opioid addiction.
Sponsored by: Mount Regis Center
Friday, June 24, 2016 | 1:30 p.m. – 2:30 p.m.
There is no one magic bullet to end the scourge of opioid addiction and overdose; this longstanding crisis defies simple solutions. In this presentation, Dr. Pringle will update attendees on a multifaceted approach to combat the opioid problem, and will discuss the efforts of key community partners. Components to be discussed include the work of The Pennsylvania Heroin Overdose Prevention Technical Assistance Center, a Center designed to support communities across the Commonwealth as they mobilize to fight the increasing issue of opioid overdose deaths.
Upon completion of this session, attendees will be able to:
- Identify the key components of a statewide strategy to combat opioid dependence.
- Articulate the role of addiction treatment providers as partners in a comprehensive response.
- Identify which segments of the community are essential to an effective crisis response.
Friday, June 24, 2016 | 3:00 - 4:00 PM
This session will provide an overview of key best practices in treating opioid use disorders in Pennsylvania. Current trends in addiction, overdose, treatment and recovery will be explored in light of collaborations to coordinate care. This session will examine the response of the commonwealth to these emerging trends. Specific topics will include medication-assisted treatment, drug of choice and overdose issues, and solutions such as provider cross-training, collaboration, and effective use of existing supports.
Upon completion of this session, attendees will be able to:
- Identify current challenges to the SUD system.
- Identify the core elements of collaborative treatment that works.
- Cite the main examples of coordinated-care approaches to combat the opioid crisis in Pennsylvania.
Friday, June 24, 2016 | 4:00 - 5:00 PM
The session will focus on the collective realization that while opiates have been around for thousands of years, major shifts in society have made opiate use and addiction a life-threatening pandemic. These shifts have to do with the synthetic production of opiates since World War II, the medical community's belief that pain is an unacceptable symptom even at low levels, and the proliferation of synthetic medications which potentiate opiate effects.
Yet more rational voices are beginning to emerge that advocate for guidelines which will prevent opiates from being so easily accessible and negotiating with patients to manage pain symptoms through rational management strategies.
Upon completion of this session, attendees will be able to:
- Learn the history of opiate use which created the current crisis
- Learn and recite the current strategies for curtailing opiate availability
- Learn and recite the individual strategies that can be taken back to their communities to effect change
